The musculoskeletal oncology program at the Duke Cancer Institute specializes in the treatment of pediatric sarcomas, including rhabdomyosarcoma, osteosarcoma, Ewing sarcoma, and other sarcomas.
Though the cause of sarcoma is still unknown, the Duke Cancer Institute is in the forefront of research to treat and cure this rare disease.
To make the treatment process easier for patients and families, Duke Cancer Institute’s multidisciplinary sarcoma clinic brings together oncologists, surgeons, and radiation oncologists, allowing patients to see multiple providers all on the same day.
This dedicated team of specialists works closely with patients and their families to create a care plan that includes support throughout the treatment process -- from diagnosis and treatment to recovery and rehabilitation.
Patients and families play an integral role in creating a treatment plan. As a patient at the Duke Cancer Institute you can be sure that the unique needs of your family are taken into account when planning all aspects of treatment.
Depending on the size, location, and stage of their tumor, patients may receive a combination of therapies including surgery, chemotherapy, and radiation therapy. We also offer a number of novel biologic therapies to fight pediatric sarcomas. Learn more about treatment for pediatric sarcomas.
Duke has long been a leader in developing treatments and therapies to fight cancer and improve quality of life. Patients have access to cutting-edge clinical trials testing the latest therapies through the Children’s Oncology Group and SARC alliance.
Learn how to make an appointment at the Duke Cancer Institute.